DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

Combining Whole Genome Sequencing with ppm-Level Sensitivity, MRDVision Sets a New Benchmark in Circulating Tumor DNA ...

By analyzing circulating biomarkers such as cfDNA, ctDNA, and CTCs, liquid biopsy enables early detection of cancer and provides a comprehensive overview of tumor biology. Lung Cancer: Liquid ...

“Unlike cfDNA, miRNA is proactively secreted by early cancer cells, making it particularly ... different cancers (pancreatic, colorectal, lung, stomach, esophagus breast, ovarian) using urinary ...

In its recent clinical validation study using cfDNA samples from post-surgical ovarian and lung cancer patients, MRDVision detected tumor-derived signals in 6% of cases that were not identified by ...

The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals' cfDNA fragments against populations with and without cancer. FirstLook Lung ...